Richard E. Champlin

77.2k citations
1.1k papers · 45.6k · 10 hit papers · h-index 114

Impact in

  • Hematology top 0.01%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.02%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Hematopoietic Stem Cell Transplantation 454
    • Acute Myeloid Leukemia Research 234
    • Chronic Myeloid Leukemia Treatments 152
    • Multiple Myeloma Research and Treatments 115
    • CAR-T cell therapy research 92

Richard E. Champlin

1.1k papers receiving 44.5k citations

Richard E. Champlin's Hit Papers

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells 2012 · 502 citations
5020+12+25Years since publication250500750

Peers

Richard E. Champlin
Comparison fields: 5 of 166
  • Hematology 25.7k
  • Genetics 7.3k
  • Transplantation 1.6k
  • Immunology 11.3k
  • Oncology 13.2k
Replace Arnon Nagler with:
Arnon Nagler Israel
Daniel J. Weisdorf United States
Sergio Giralt United States
Rainer Storb United States
Paul J. Martin United States
Gèrard Socié France
Frederick R. Appelbaum United States
Éliane Gluckman France
Olle Ringdén Sweden
H. Joachim Deeg United States
Richard E. Champlin relative to Arnon Nagler Israel Arnon Nagler's profile →
Citations per field
00.5×1.7×
Arnon Nagler · 1×
Citations per year

Countries citing papers authored by Richard E. Champlin

Since Specialization
Citations

This map shows the geographic impact of Richard E. Champlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Champlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Champlin more than expected).

Fields of papers citing papers by Richard E. Champlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Champlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Champlin. The network helps show where Richard E. Champlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Richard E. Champlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard E. Champlin Line = papers co-authored together Richard E. Champlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.

#Work
1
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
Hit paper breakdown →
1997998
2
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
Hit paper breakdown →
1997907
3
Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia
Hit paper breakdown →
2004785
4
Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.
Hit paper breakdown →
2002766
5
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
Hit paper breakdown →
1998737
6
Hepatocytes and Epithelial Cells of Donor Origin in Recipients of Peripheral-Blood Stem Cells
Hit paper breakdown →
2002610
7
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.
Hit paper breakdown →
1988604
8
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study
Hit paper breakdown →
2007558
9
Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
Hit paper breakdown →
2000532
10
Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
Hit paper breakdown →
2012502
11 2005490
12 2001444
13 2001436
14 2012419
15 2010402
16 2000401
17 2016353
18 2015333
19 2010324
20 2004307

About Richard E. Champlin

Richard E. Champlin is a scholar working on Hematology, Oncology, Genetics, Immunology and Public Health, Environmental and Occupational Health, having authored 1.1k papers that have together received 45.6k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (454 papers), Acute Myeloid Leukemia Research (234 papers), Chronic Myeloid Leukemia Treatments (152 papers), Acute Lymphoblastic Leukemia research (146 papers), Chronic Lymphocytic Leukemia Research (123 papers), Multiple Myeloma Research and Treatments (115 papers), Immune Cell Function and Interaction (109 papers) and CAR-T cell therapy research (92 papers). The work is most often cited by research in Hematology (25.7k citations), Genetics (7.3k citations), Transplantation (1.6k citations), Immunology (11.3k citations) and Oncology (13.2k citations). Richard E. Champlin has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Sergio Giralt, Issa F. Khouri, Börje S. Andersson, Paolo Anderlini, Robert Peter Gale, Elizabeth J. Shpall, Marcos de Lima, Gabriela Rondón, Chitra Hosing and Hagop M. Kantarjian. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact